Skip to content

Cohealyx™ BDCDM1020Recalls & reported problems

Collagen Matrix, Inc. · Collagen Dermal Matrix · Class U

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00813954026596), received between Oct 17, 2025 and Oct 17, 2025 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 17, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    DURING AN ONGOING CLINICAL STUDY INVOLVING THE COHEALYX PRODUCT, A SERIOUS ADVERSE EVENT OF "GRAFT LOSS" DEEMED POSSIBLY RELATED TO THE PRODUCT WAS NOTED. DETAILS SURROUNDING INITIAL SURGERY WERE NOT SPECIFIED, BUT THE COHEALYX PRODUCT WAS INITIALLY SECURED AND HYDRATED ON (B)(6) 2025. GRAFT PLACEMENT PERFORMED 12 DAYS LATER ON 9/6/2025. THE SERIOUS ADVERSE EVENT OF GRAFT LOSS WAS REPORTED ON (B)(6) 2025. A REGRAFT WAS PERFORMED ON(B)(6) 2025, IN WHICH THE PATIENT'S OWN SKIN (MESHED SPLIT-THICKNESS SKIN GRAFT) AND RECELL (NOT A COLLAGEN MATRIX, INC. PRODUCT) WERE USED. THE COHEALYX PRODUCT WAS NOT EXPLANTED. THE RE-GRAFT WAS COMPLETED SUCCESSFULLY AND THE OUTCOME OF THE INITIAL SERIOUS ADVERSE EVENT WAS REPORTED AS 'RECOVERED/RESOLVED.' NO FURTHER INFORMATION SURROUNDING THE EVENT, PATIENT OUTCOME, OR PATIENT STATUS WILL BE PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23327523 ↗

Other Wound Dressing With Animal-Derived Material(S) devices

All Wound Dressing With Animal-Derived Material(S) devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.